Glofitamab Regimen Improves Survival in DLBCL Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
Using MRD Status to Deescalate Multiple Myeloma Therapy Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia "Rapid and sustained" efficacy in 95% of pretreated patients in small trial Jun 19, 2024
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer New indications for pembrolizumab and durvalumab in advanced disease Jun 17, 2024
New Standard of Care in High-Risk Acute Promyelocytic Leukemia? All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
I Tried to Protect My Mother From Dying in Pain. The Law Robbed Her of That Dignity. It's time to clear the roadblocks to Medical Aid in Dying in the U.S. Jun 16, 2024
Train Eyes So Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke Also in TTHealthWatch: cancers subsequent to CAR-T therapy Jun 15, 2024 podcast
Atezolizumab Consolidation Impresses in High-Risk DLBCL Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
Kate Middleton Gives Cancer Update Princess of Wales says she's making "good progress" in treatment Jun 14, 2024
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO Jun 14, 2024 video
Early Menopause Tied to Higher Risk of Respiratory Mortality Greatest risk observed for women with bilateral oophorectomy Jun 13, 2024
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? News, features, and commentary about cancer-related issues Jun 13, 2024
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer AI detected 6.8% more clinically significant cancers, 20% fewer indolent cancers Jun 13, 2024
Tanning Salons Are Overdue for a Regulatory Burn In the meantime, don't forget to educate patients on the risks Jun 13, 2024
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer No difference in PFS, median OS favored control group Jun 12, 2024
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer Half of patients responded, but editorialists call for new directions in therapy development Jun 11, 2024
Middle-Age Man Presents With Necrotizing Mass on Nose Rare condition can be deadly without early diagnosis and treatment Jun 10, 2024
Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma Immunotherapy may have been given too late, researchers suggested Jun 10, 2024
Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South But one study showed that patient navigation added to usual care may increase uptake Jun 10, 2024
Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
Telomerase Inhibitor Approved for MDS-Related Anemia Imetelstat indicated for lower-risk myelodysplastic syndromes with transfusion-dependent anemia Jun 07, 2024
Search for Missing Doctor; Energy Drinks and Sudden Death; Unusual Pandemic Cancers Health news and commentary gathered by Ƶ staff Jun 07, 2024
Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapy All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Shows Adding ARSIs to ADT for advanced disease doubled the risk of high-grade CV events, death Jun 06, 2024
'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trial News, features, and commentary about cancer-related issues Jun 06, 2024
Metformin Fails to Stop Early Prostate Cancer Progression Study suggests it may even be detrimental in some groups of patients on active surveillance Jun 05, 2024
Docetaxel Tied to Less Taxane Neuropathy in Black Breast Cancer Patients Dose-limiting toxicity has been linked with worse outcomes specifically in this population Jun 05, 2024
Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brains Health news and commentary gathered by Ƶ staff Jun 05, 2024
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma Two trials show positive outcomes Jun 04, 2024
Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma A third as many clinical events versus adjuvant therapy, 6 weeks of treatment for many patients Jun 04, 2024
ctDNA Analysis Not Enough to Guide Chemo De-Escalation in Early Pancreatic Cancer Adjuvant chemo de-escalation based on ctDNA had no effect on recurrence-free survival Jun 04, 2024
A Win for Liver Transplantation in Unresectable Metastatic Colorectal Cancer Three new trials address CRC liver metastases Jun 04, 2024
New Drug Effective for Tenosynovial Giant Cell Tumors, and With No Liver Concerns Current option for rare tumor requires a REMS to monitor for drug-induced liver injury Jun 04, 2024
Industry Clinic • Ad Insights What Will It Take to Deliver Both Health & Care in Oncology? Jun 04, 2024
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers Clear cell histology "is what yields the super response we see in these trials," expert suggests Jun 04, 2024
IRS Sues Controversial Doctor; Congresswoman Has Cancer; Caffeine and Teens Health news and commentary gathered by Ƶ staff Jun 04, 2024